C.R. Bard, Lutonix deal

Bard acquired Lutonix for $225 million in cash plus an additional $100 million based on FDA approval of a PMA for Lutonix's Moxy Drug-Coated Balloon. The paclitaxel-coated balloon catheter is in a pi...